Celeris Therapeutics
PrivateCompany Overview
Celeris Therapeutics operates in Healthcare & Life Sciences and is based in Menlo Park, California. It was founded in 2020.
Celeris Therapeutics is a biotechnology company that develops AI-driven degrader drugs for undruggable proteins linked to oncology and central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celeris Therapeutics Comparables
Compare Celeris Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 84% | |
| Ternary Therapeutics | 81% | |
| Neomorph | 81% |
For institutional investors. Book with your work email.
Celeris Therapeutics Funding Rounds
Historical fundraising activity
Celeris Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Celeris Therapeutics's valuation, stock price, and market status.
Is Celeris Therapeutics a public or private company?
Celeris Therapeutics is a private company.
What is the current stock price of Celeris Therapeutics?
Celeris Therapeutics is a private company, so its shares have no public market price. Caplight tracks Celeris Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celeris Therapeutics worth (valuation)?
Valuation information for Celeris Therapeutics is not publicly available.
Can I buy Celeris Therapeutics stock?
Celeris Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celeris Therapeutics's last funding round?
Funding round information for Celeris Therapeutics is not publicly available.
Who are the main investors in Celeris Therapeutics?
Investor information for Celeris Therapeutics is not publicly disclosed.
Will Celeris Therapeutics IPO soon?
No public IPO plans have been announced for Celeris Therapeutics.
How can I track Celeris Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Celeris Therapeutics's shares on secondary markets.